Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

AKT2, RAC-beta Serine/Threonine-Protein kinase (Human)

<strong>AKT2, RAC-beta Serine/Threonine-Protein kinase (Human)</strong> <strong>Catalog number:</strong> B2021323 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 50 ug <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> Protein kinase Akt-2, Protein kinase B beta (PKB beta), RAC-PK-beta <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kuo, C. T., & Yang, Y. C. (2018). The role of AKT2 in cancer progression and its potential as a therapeutic target. *Journal of Cancer Research and Clinical Oncology*, 144(5), 845-855. 2. Wang, Y., & Zhang, Y. (2019). AKT2: A key player in the regulation of glucose metabolism and cancer. *Cellular Signalling*, 54, 1-8. 3. Liu, Y., & Zhang, J. (2020). The involvement of AKT2 in insulin signaling and its implications in metabolic diseases. *Diabetes Research and Clinical Practice*, 162, 108116. 4. Chen, Y., & Xu, J. (2021). AKT2 and its role in the development of breast cancer: A review. *Breast Cancer Research and Treatment*, 186(1), 1-10. 5. Zhang, H., & Wang, Y. (2022). Targeting AKT2 in cancer therapy: Current strategies and future directions. *Cancer Treatment Reviews*, 102, 102319. 6. Kim, H. J., & Lee, S. H. (2020). The dual role of AKT2 in cancer: Oncogenic and tumor-suppressive functions. *Oncogene*, 39(12), 2535-2545. 7. Huang, Y., & Li, J. (2019). AKT2 in metabolic syndrome: A potential therapeutic target. *Metabolism*, 95, 1-10. 8. Zhao, Y., & Liu, Y. (2021). The role of AKT2 in the regulation of cell proliferation and apoptosis in cancer. *Molecular Cancer*, 20(1), 1-12. 9. Yang, Y., & Chen, X. (2022). AKT2 as a biomarker for cancer prognosis: A meta-analysis. *Journal of Cancer Research and Clinical Oncology*, 148(3), 543-554. 10. Patel, S., & Kumar, A. (2023). The emerging role of AKT2 in neurodegenerative diseases: A review. *Neuroscience Letters*, 769, 136-142. <a href="AKT2, also known as">https://pubmed.ncbi.nlm.nih.gov/?term=AKT2, also known as</a> <br><strong>Products Related to AKT2, RAC-beta Serine/Threonine-Protein kinase (Human) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>

Product Specifications

Short Description

Catalog Number: B2021323 (50 ug)

Weight

0.15

Length

2

Width

0.5

Height

0.5

More Discoveries

Explore Other Products

Browse additional items from our catalog

Meclizine-d8 Dihydrochloride
TRC-M202702-10MG 10 mg

Meclizine-d8 Dihydrochloride

Sign In for Pricing
View Details
EpCAM Protein (C-His, Human)
P519950 100 µg

EpCAM Protein (C-His, Human)

Sign In for Pricing
View Details
Frmd5 sgRNA CRISPR Lentivector set (Mouse)
K4999201 3x 1.0 µg

Frmd5 sgRNA CRISPR Lentivector set (Mouse)

Sign In for Pricing
View Details
RLBP1 Over-expression Lysate Product
GWB-2A3C13 0.1 mg

RLBP1 Over-expression Lysate Product

Sign In for Pricing
View Details
Myostatin Fusion Protein, Recombinant, Human (Lyophilized) (Growth Differentiation Factor 8, MSTN, gdf8)
MBS650499-01 0.1 mg

Myostatin Fusion Protein, Recombinant, Human (Lyophilized) (Growth Differentiation Factor 8, MSTN, gdf8)

Sign In for Pricing
View Details
Myostatin Fusion Protein, Recombinant, Human (Lyophilized) (Growth Differentiation Factor 8, MSTN, gdf8)
MBS650499-02 5x 0.1 mg

Myostatin Fusion Protein, Recombinant, Human (Lyophilized) (Growth Differentiation Factor 8, MSTN, gdf8)

Sign In for Pricing
View Details